Functional high capacity exosome-encapsulating bioinspired hydrogel promotes microvascular bed expansion in diabetic mice

Bibi S Subhan,Juan F Cortes Troncoso,Priya Katyal,Michael Meleties,Tamara Mestvirishvili,Fernando Arias,Andrew Wang,Kelly Ruggles,Igor Dolgalev,Paolo Mita,Jin Kim Montclare,Piul S Rabbani
DOI: https://doi.org/10.1101/2024.08.23.609402
2024-08-26
Abstract:Chronic wounds present a significant clinical challenge due to impaired skin microvasculature, particularly in diabetes. The tissue engineering study introduces therapeutic Exo-Q, a unique thermoresponsive polymer hydrogel created with Q protein nanofibers and cultured human bone marrow multipotent stromal cell exosomes with consistent gene signature. Limited, local and topical application of Exo-Q hydrogel is feasible for maximum neovascularization during murine diabetic wound closure in a xenotransplantation model, as well as compatibility and vascular delivery in human skin in a xenograft model. Exo-Q hydrogel treatment significantly reduces diabetic wound closure time within ranges of non-diabetic wounds. This innovative, non-invasive tissue engineered therapeutic option offers a promising approach to addressing the complex pathologies of non-healing wounds.
Bioengineering
What problem does this paper attempt to address?